FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2604749499> ?p ?o ?g. }

• W2604749499 endingPage "2653" @default.
• W2604749499 startingPage "2647" @default.
• W2604749499 abstract "Polio is on the brink of eradication. Improved inactivated polio vaccines (IPV) are needed towards complete eradication and for the use in the period thereafter. Vaccination via mucosal surfaces has important potential advantages over intramuscular injection using conventional needle and syringe, the currently used delivery method for IPV. One of them is the ability to induce both serum and mucosal immune responses: the latter may provide protection at the port of virus entry. The current study evaluated the possibilities of polio vaccination via mucosal surfaces using IPV based on attenuated Sabin strains. Mice received three immunizations with trivalent sIPV via intramuscular injection, or via the intranasal or sublingual route. The need of an adjuvant for the mucosal routes was investigated as well, by testing sIPV in combination with the mucosal adjuvant cholera toxin. Both intranasal and sublingual sIPV immunization induced systemic polio-specific serum IgG in mice that were functional as measured by poliovirus neutralization. Intranasal administration of sIPV plus adjuvant induced significant higher systemic poliovirus type 3 neutralizing antibody titers than sIPV delivered via the intramuscular route. Moreover, mucosal sIPV delivery elicited polio-specific IgA titers at different mucosal sites (IgA in saliva, fecal extracts and intestinal tissue) and IgA-producing B-cells in the spleen, where conventional intramuscular vaccination was unable to do so. However, it is likely that a mucosal adjuvant is required for sublingual vaccination. Further research on polio vaccination via sublingual mucosal route should include the search for safe and effective adjuvants, and the development of novel oral dosage forms that improve antigen uptake by oral mucosa, thereby increasing vaccine immunogenicity. This study indicates that both the intranasal and sublingual routes might be valuable approaches for use in routine vaccination or outbreak control in the period after complete OPV cessation and post-polio eradication." @default.
• W2604749499 created "2017-04-14" @default.
• W2604749499 creator A5006689267 @default.
• W2604749499 creator A5025764334 @default.
• W2604749499 creator A5081039444 @default.
• W2604749499 creator A5086006646 @default.
• W2604749499 date "2017-05-01" @default.
• W2604749499 modified "2023-09-24" @default.
• W2604749499 title "Intranasal and sublingual delivery of inactivated polio vaccine" @default.
• W2604749499 cites W1541762857 @default.
• W2604749499 cites W1916435595 @default.
• W2604749499 cites W1971110767 @default.
• W2604749499 cites W1979435678 @default.
• W2604749499 cites W1981732883 @default.
• W2604749499 cites W2002392006 @default.
• W2604749499 cites W2002712227 @default.
• W2604749499 cites W2006732948 @default.
• W2604749499 cites W2010129113 @default.
• W2604749499 cites W2030796658 @default.
• W2604749499 cites W2033333432 @default.
• W2604749499 cites W2033620269 @default.
• W2604749499 cites W2036533635 @default.
• W2604749499 cites W2063501816 @default.
• W2604749499 cites W2064953453 @default.
• W2604749499 cites W2068583880 @default.
• W2604749499 cites W2072522367 @default.
• W2604749499 cites W2074325607 @default.
• W2604749499 cites W2078990163 @default.
• W2604749499 cites W2085230212 @default.
• W2604749499 cites W2087649686 @default.
• W2604749499 cites W2091763807 @default.
• W2604749499 cites W2093714035 @default.
• W2604749499 cites W2094771034 @default.
• W2604749499 cites W2120321064 @default.
• W2604749499 cites W2161689282 @default.
• W2604749499 cites W2165886375 @default.
• W2604749499 cites W2283292026 @default.
• W2604749499 cites W2314346321 @default.
• W2604749499 cites W2395945700 @default.
• W2604749499 cites W2476461671 @default.
• W2604749499 cites W2525883689 @default.
• W2604749499 doi "https://doi.org/10.1016/j.vaccine.2017.03.090" @default.
• W2604749499 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28400164" @default.
• W2604749499 hasPublicationYear "2017" @default.
• W2604749499 type Work @default.
• W2604749499 sameAs 2604749499 @default.
• W2604749499 citedByCount "13" @default.
• W2604749499 countsByYear W26047494992018 @default.
• W2604749499 countsByYear W26047494992019 @default.
• W2604749499 countsByYear W26047494992021 @default.
• W2604749499 countsByYear W26047494992022 @default.
• W2604749499 countsByYear W26047494992023 @default.
• W2604749499 crossrefType "journal-article" @default.
• W2604749499 hasAuthorship W2604749499A5006689267 @default.
• W2604749499 hasAuthorship W2604749499A5025764334 @default.
• W2604749499 hasAuthorship W2604749499A5081039444 @default.
• W2604749499 hasAuthorship W2604749499A5086006646 @default.
• W2604749499 hasBestOaLocation W26047494991 @default.
• W2604749499 hasConcept C159047783 @default.
• W2604749499 hasConcept C159654299 @default.
• W2604749499 hasConcept C203014093 @default.
• W2604749499 hasConcept C22070199 @default.
• W2604749499 hasConcept C22889606 @default.
• W2604749499 hasConcept C2522874641 @default.
• W2604749499 hasConcept C2777863537 @default.
• W2604749499 hasConcept C2779631682 @default.
• W2604749499 hasConcept C2780801004 @default.
• W2604749499 hasConcept C2908689829 @default.
• W2604749499 hasConcept C32611913 @default.
• W2604749499 hasConcept C4870876 @default.
• W2604749499 hasConcept C71924100 @default.
• W2604749499 hasConcept C85663871 @default.
• W2604749499 hasConcept C86803240 @default.
• W2604749499 hasConcept C8891405 @default.
• W2604749499 hasConcept C89423630 @default.
• W2604749499 hasConceptScore W2604749499C159047783 @default.
• W2604749499 hasConceptScore W2604749499C159654299 @default.
• W2604749499 hasConceptScore W2604749499C203014093 @default.
• W2604749499 hasConceptScore W2604749499C22070199 @default.
• W2604749499 hasConceptScore W2604749499C22889606 @default.
• W2604749499 hasConceptScore W2604749499C2522874641 @default.
• W2604749499 hasConceptScore W2604749499C2777863537 @default.
• W2604749499 hasConceptScore W2604749499C2779631682 @default.
• W2604749499 hasConceptScore W2604749499C2780801004 @default.
• W2604749499 hasConceptScore W2604749499C2908689829 @default.
• W2604749499 hasConceptScore W2604749499C32611913 @default.
• W2604749499 hasConceptScore W2604749499C4870876 @default.
• W2604749499 hasConceptScore W2604749499C71924100 @default.
• W2604749499 hasConceptScore W2604749499C85663871 @default.
• W2604749499 hasConceptScore W2604749499C86803240 @default.
• W2604749499 hasConceptScore W2604749499C8891405 @default.
• W2604749499 hasConceptScore W2604749499C89423630 @default.
• W2604749499 hasIssue "20" @default.
• W2604749499 hasLocation W26047494991 @default.
• W2604749499 hasLocation W26047494992 @default.
• W2604749499 hasLocation W26047494993 @default.
• W2604749499 hasOpenAccess W2604749499 @default.
• W2604749499 hasPrimaryLocation W26047494991 @default.

• next